Q4 2025 · 13F-HR
Seven Fleet Capital Management LPholdings as filed
Filed 2026-02-26 · accession 0001013594-26-000305
$131.5M
Reported value
85
Positions
2025-12-31
Period end
The Brief · Seven Fleet Capital Management LP · Q4 2025
AI · grounded in 13F
Seven Fleet Capital Management LP established a new position in CGON valued at $62.9M. The fund also initiated new stakes in SLNO for $6.0M and RVMD for $5.2M. Additional new positions include LQDA, CMPX, and EXEL.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 156944100 | CGON | CG ONCOLOGY INC | $62.9M | 47.8% | 1,515,151 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $6.0M | 4.58% | 130,079 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $5.2M | 3.99% | 65,800 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $3.1M | 2.39% | 91,267 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $3.1M | 2.32% | 568,747 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $3.0M | 2.29% | 68,569 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $2.4M | 1.80% | 12,955 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $2.1M | 1.59% | 79,560 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $1.9M | 1.46% | 54,025 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $1.9M | 1.45% | 215,172 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $1.7M | 1.28% | 109,554 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $1.5M | 1.17% | 55,342 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.5M | 1.13% | 36,894 | Common | SOLE |
| 07782B104 | BLTE | BELITE BIO INC | $1.5M | 1.11% | 9,161 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $1.4M | 1.04% | 70,180 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $1.3M | 0.96% | 12,601 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $1.2M | 0.92% | 5,670 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $1.2M | 0.89% | 82,500 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.2M | 0.89% | 25,365 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $1.2M | 0.87% | 63,343 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $1.1M | 0.83% | 533,648 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $1.1M | 0.82% | 1,860 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $1.0M | 0.78% | 777,880 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $986,160 | 0.75% | 4,000 | Common | SOLE |
| 04746L203 | LONA | ATHIRA PHARMA INC | $968,589 | 0.74% | 127,951 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $919,727 | 0.70% | 167,223 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $897,408 | 0.68% | 147,600 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $872,460 | 0.66% | 166,500 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $863,908 | 0.66% | 31,738 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $795,798 | 0.61% | 2,700 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $782,859 | 0.60% | 7,849 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $781,854 | 0.59% | 48,412 | Common | SOLE |
| 696389402 | PALI | PALISADE BIO INC | $769,625 | 0.59% | 327,500 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $744,346 | 0.57% | 154,109 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $698,720 | 0.53% | 8,000 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $668,413 | 0.51% | 3,026 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $656,686 | 0.50% | 10,335 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $634,200 | 0.48% | 15,000 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $633,425 | 0.48% | 130,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $617,580 | 0.47% | 73,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $603,768 | 0.46% | 14,651 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $574,028 | 0.44% | 18,200 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $553,168 | 0.42% | 15,243 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $545,300 | 0.41% | 82,000 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $542,398 | 0.41% | 20,600 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $461,945 | 0.35% | 56,750 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $456,032 | 0.35% | 14,654 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $413,515 | 0.31% | 43,300 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $379,400 | 0.29% | 20,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $378,455 | 0.29% | 62,762 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $368,460 | 0.28% | 4,500 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $337,330 | 0.26% | 276,500 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $323,331 | 0.25% | 107,419 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $319,087 | 0.24% | 11,445 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $305,600 | 0.23% | 76,400 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $276,000 | 0.21% | 40,000 | Common | SOLE |
| M40527109 | ENTX | ENTERA BIO LTD | $262,517 | 0.20% | 135,318 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $211,080 | 0.16% | 6,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $209,196 | 0.16% | 8,742 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $208,305 | 0.16% | 48,898 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $207,594 | 0.16% | 17,100 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $179,995 | 0.14% | 11,688 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $158,824 | 0.12% | 5,240 | Common | SOLE |
| 045396207 | ASMB | ASSEMBLY BIOSCIENCES INC | $146,753 | 0.11% | 4,315 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $140,320 | 0.11% | 4,000 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $139,778 | 0.11% | 11,571 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $135,864 | 0.10% | 1,800 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $133,133 | 0.10% | 117,817 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $116,881 | 0.09% | 15,140 | Common | SOLE |
| G7487R100 | RGC | REGENCELL BIOSCIENCE HLDGS L | $92,400 | 0.07% | 4,400 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $89,017 | 0.07% | 7,110 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $82,843 | 0.06% | 155,223 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $79,373 | 0.06% | 63,498 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $62,720 | 0.05% | 4,000 | Common | SOLE |
| 68232V884 | TRAW | TRAWS PHARMA INC | $55,664 | 0.04% | 49,260 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $52,360 | 0.04% | 4,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $49,630 | 0.04% | 2,000 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $41,502 | 0.03% | 62,701 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $35,798 | 0.03% | 2,270 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $31,050 | 0.02% | 3,000 | Common | SOLE |
| 37148K209 | — | GENERATION BIO CO | $30,536 | 0.02% | 5,376 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $9,342 | 0.01% | 337 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS ORD | $9,060 | 0.01% | 6,000 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $1,618 | 0.00% | 12 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $1,206 | 0.00% | 200 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.